Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping

Tue, 08 Sep 2026 09:00:00 -0400

New York State Department of Health approval allows clinical use of optical genome mapping (OGM) based lab developed tests (LDTs) for patients with suspected genetic disease, reproductive disorders, and hematologic malignancies at University of Rochester Medicine

SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed test (LDTs), today announced that the New York State Department of Health (NYSDOH) has approved the use of optical genome mapping (OGM)-based LDTs for the clinical evaluation of samples from patients suspected of various genetic disorders including reproductive disorders

Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping

Tue, 08 Sep 2026 09:00:00 -0400

Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Mon, 24 Aug 2026 08:00:00 -0400

SAN DIEGO, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that management will present and host 1x1 meetings at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026.

Conference & Webcast Details

SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2026.

"Our second quarter results reflect a strong vote of confidence from our routine use customer community and the accelerating global adoption of optical genome mapping (OGM)," commented Al Luderer, Ph.D., chairman and interim chief executive officer of Bionano. "The evidence base supporting OGM continued to expand across a broad range of research areas, reflected by the year-over-year increase in OGM studies presented

Bionano Reports Second Quarter 2026 Results and Provides a Business Update

Mon, 10 Aug 2026 16:05:00 -0400

Conference call today, August 10, 2026, at 4:30 PM ET

SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2026.

Form 8-K Bionano Genomics, Inc. For: Aug 10

Mon, 10 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260810/26897753.html

Form 8-K Bionano Genomics, Inc. For: Aug 10

Mon, 10 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260810/26897753.html

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Dixon Jonathan V.

Wed, 05 Aug 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260805/26876100.html

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Dixon Jonathan V.

Wed, 05 Aug 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260805/26876100.html

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Adamchak Mark

Wed, 05 Aug 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260805/26876102.html

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Adamchak Mark

Wed, 05 Aug 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260805/26876102.html

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Hastie Alex Reid

Wed, 05 Aug 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260805/26876087.html

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Hastie Alex Reid

Wed, 05 Aug 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260805/26876087.html

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: OLDAKOWSKI MARK

Wed, 05 Aug 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260805/26876092.html

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: OLDAKOWSKI MARK

Wed, 05 Aug 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260805/26876092.html

Form 3 Bionano Genomics, Inc. For: Aug 03 Filed by: OLDAKOWSKI MARK

Wed, 05 Aug 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260805/26873553.html

Form 3 Bionano Genomics, Inc. For: Aug 03 Filed by: OLDAKOWSKI MARK

Wed, 05 Aug 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260805/26873553.html

Form 3 Bionano Genomics, Inc. For: Aug 03 Filed by: Dixon Jonathan V.

Wed, 05 Aug 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260805/26873556.html

StreetInsider.com News Articles

Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping

Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping

Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Bionano Reports Second Quarter 2026 Results and Provides a Business Update

Form 8-K Bionano Genomics, Inc. For: Aug 10

Form 8-K Bionano Genomics, Inc. For: Aug 10

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Dixon Jonathan V.

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Dixon Jonathan V.

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Adamchak Mark

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Adamchak Mark

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Hastie Alex Reid

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: Hastie Alex Reid

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: OLDAKOWSKI MARK

Form 4 Bionano Genomics, Inc. For: Aug 03 Filed by: OLDAKOWSKI MARK

Form 3 Bionano Genomics, Inc. For: Aug 03 Filed by: OLDAKOWSKI MARK

Form 3 Bionano Genomics, Inc. For: Aug 03 Filed by: OLDAKOWSKI MARK

Form 3 Bionano Genomics, Inc. For: Aug 03 Filed by: Dixon Jonathan V.